The prefix “epi” typically connotes being above or at the surface level of something. However, research at the intersection of epigenetics and epidemiology probes our understanding of the interaction between genes and environmental factors to the deepest levels.
Epidemiologists and medical professionals argue that the risk of a second wave of infection of the coronavirus (COVID-19) could outweigh any prospective economic gains. Dr. Alfred Sommer, dean emeritus of the Bloomberg School of Public Health, gave a webinar entitled “Do You Really Want to Hear From an Epidemiologist at a Time Like This?” on this very topic last Thursday.
As the number of coronavirus (COVID-19) cases surge, so do treatment options. A new solution proposed by Dr. Arturo Casadevall, an immunologist at the Hopkins School of Medicine, has recently moved into clinical trials after fast-track approval from the U.S. Food and Drug Administration (FDA).
Hopkins is known for the strength of its STEM curriculum and for the number of undergraduates immersed in some kind of scientific research on campus. Outside of the Homewood Campus, institutions like the Baltimore Underground Science Space, the Maryland Science Center and the National Aquarium make Baltimore an exciting place for scientific exploration.
The National Aeronautics and Space Administration (NASA) is looking at the earth’s closest celestial neighbor as potential real estate for its newest telescope. In a press release on April 7, NASA announced that the NASA Innovative Advanced Concepts (NIAC) program would be awarding a total of $7 million to 23 “potentially revolutionary concepts” in early-stage tech development.
Nine research groups comprising experts across University divisions have been established at Hopkins to study COVID-19. The News-Letter had the opportunity to interview three researchers leading these efforts.
News about the coronavirus (COVID-19) pandemic can seem like a hotbed of paradoxical information, lacking in clear answers because there is still so much to learn. While it is important to stay informed and aware about what exactly is going on, knowing what questions to ask can be just as hard as finding the right answers.
A team at Hopkins is working to develop a ventilator splitter that will allow hospitals to maximize the utility of their existing ventilators. As the number of cases of coronavirus (COVID-19) rapidly increases, hospitals across the nation are struggling to manage the influx of patients with insufficient supplies.
My fellow Quaren-teens, Hopefully by now you are all becoming situated in your new normals and finding new ways of surviving and thriving in whichever corner of the globe this madness has flung you into. If you’re at all like me, your mind has probably gone absolutely bonkers at some point over the past four weeks.
Two Hopkins clinical microbiologists — Dr. Karen Carroll and Dr. Heba Mostafa — have recently developed a coronavirus (COVID-19) screening test that may soon allow the Hopkins health system to test as many as 1,000 people per day.
For many of us, social distancing — forbidding large gatherings and keeping six feet away from others — is quickly becoming the new normal. As leaders in public health suggest that this may be the best way for us all to survive the pandemic, “flattening the curve” has become a mantra that unites us all.
As the number of people with the coronavirus (COVID-19) rises steadily, hospitals contend with a possible overflow of patients and face difficult decisions. With the lack of adequate medical supplies, how do health-care workers choose between patients when distributing limited life-saving treatment?
As the coronavirus (COVID-19) crisis intensifies across the U.S., now accounting for 20 percent of global cases, the American people heavily depend on the actions of the government for their health and safety. At the center of this response are two individuals — President Donald Trump and Dr. Anthony Fauci.
As the novel coronavirus (COVID-19) spreads across America, shortages in ventilators and personal protective equipment (PPE) are becoming increasingly dire for health-care providers in this crisis.
Since the novel coronavirus (COVID-19) predominantly affects the respiratory system, several studies have looked at the connection between smoking or vaping and the risk of COVID-19 infection. Scientists suspect that smoking and vaping increase a person’s risk of severe COVID-19.
As the number of cases of coronavirus (COVID-19) surges in the U.S., a shortage of medical supplies has emerged, among which personal protective equipment (PPE) such as masks and gloves have taken the greatest hit. The shortage is in part the result of public panic, which has resulted in many citizens buying these supplies in bulk.
The Hopkins School of Advanced International Studies held a webinar titled “The Coronavirus Crisis: Responses in China, Italy, and the United States” on March 26 to discuss responses to the coronavirus (COVID-19) from a global political standpoint.
Due to the ongoing coronavirus (COVID-19) pandemic, most labs at Hopkins — apart from those researching the virus — have closed. The closure has disrupted the work of many researchers in the Hopkins community.
Since the start of the COVID-19 outbreak, scientists in both the public and private sectors have been testing various experimental vaccines to curtail long-term damage of the virus.
